loadpatents
name:-0.032427072525024
name:-0.014264106750488
name:-0.007404088973999
Blanchetot; Christophe Patent Filings

Blanchetot; Christophe

Patent Applications and Registrations

Patent applications and USPTO patent grants for Blanchetot; Christophe.The latest application filed is for "fcrn antagonists and methods of use".

Company Profile
10.16.29
  • Blanchetot; Christophe - Destelbergen BE
  • BLANCHETOT; Christophe - Ghent BE
  • BLANCHETOT; Christophe - Gent BE
  • BLANCHETOT; Christophe - Zwijnaarde BE
  • Blanchetot; Christophe - Breda NL
  • Blanchetot; Christophe - Gouda N/A NL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Fcrn Antagonists And Methods Of Use
App 20220275035 - Ulrichts; Peter ;   et al.
2022-09-01
Antibodies To Human Complement Factor C2b And Methods Of Use
App 20220267424 - Blanchetot; Christophe ;   et al.
2022-08-25
Therapeutic Musk Antibodies
App 20220259304 - BURDEN; Steven J. ;   et al.
2022-08-18
ANTI-IgE ANTIBODIES
App 20220177604 - SAUNDERS; Michael ;   et al.
2022-06-09
METHOD OF PREPARING pH-DEPENDENT ANTIBODIES
App 20220177555 - BLANCHETOT; Christophe ;   et al.
2022-06-09
Antibodies To Human Complement Factor C2b And Methods Of Use
App 20220119509 - BLANCHETOT; Christophe ;   et al.
2022-04-21
Il-6 Binding Molecules
App 20220073604 - BLANCHETOT; Christophe ;   et al.
2022-03-10
Antibodies that specifically bind to human complement factor C2b
Grant 11,161,900 - Blanchetot , et al. November 2, 2
2021-11-02
Galectin-10 Antibodies
App 20210332140 - PERCIER; Jean-Michel ;   et al.
2021-10-28
IL-6 binding molecules
Grant 11,117,959 - Blanchetot , et al. September 14, 2
2021-09-14
Galectin-10 antibodies
Grant 11,066,473 - Percier , et al. July 20, 2
2021-07-20
Combined Antagonists Against Il-5/il-5r And Either Il-4/il-4r Or Il-13/il-13r
App 20200399382 - BLANCHETOT; Christophe ;   et al.
2020-12-24
Antibodies To Human Complement Factor C2b And Methods Of Use
App 20200239554 - Blanchetot; Christophe ;   et al.
2020-07-30
Galectin-10 Antibodies
App 20190367619 - PERCIER; Jean-Michel ;   et al.
2019-12-05
Il-6 Binding Molecules
App 20190233509 - BLANCHETOT; Christophe ;   et al.
2019-08-01
Bispecific Antigen Binding Construct
App 20190218310 - VAN DER WONING; Sebastian ;   et al.
2019-07-18
FCRN antagonists and methods of use
Grant 10,316,073 - Ulrichts , et al.
2019-06-11
IL-6 binding molecules
Grant 10,183,995 - Blanchetot , et al. Ja
2019-01-22
Fcrn Antagonists And Methods Of Use
App 20180179258 - Ulrichts; Peter ;   et al.
2018-06-28
Chimeric human-llama antigens and methods of use
Grant 9,926,364 - De Haard , et al. March 27, 2
2018-03-27
Amino acid sequences directed against cellular receptors for viruses and bacteria
Grant 9,803,018 - Blanchetot , et al. October 31, 2
2017-10-31
Amino acid sequences directed against GPCRS and polypeptides comprising the same for the treatment of GPCR-related diseases and disorders
Grant 9,512,236 - Adams , et al. December 6, 2
2016-12-06
Methods Of Reducing Serum Levels Of Fc-containing Agents Using Fcrn Antagonists
App 20160264669 - Ulrichts; Peter ;   et al.
2016-09-15
Antibodies To Complex Targets
App 20160207996 - Ulrichts; Peter ;   et al.
2016-07-21
Amino acid sequences directed against CXCR4 and other GPCRs and compounds comprising the same
Grant 9,212,226 - Blanchetot , et al. December 15, 2
2015-12-15
Amino Acid Sequences Directed Against Cellular Receptors For Viruses And Bacteria
App 20150299327 - Blanchetot; Christophe ;   et al.
2015-10-22
Amino acid sequences directed against a metalloproteinase from the ADAM family and polypeptides comprising the same for the treatment of ADAM-related diseases and disorders
Grant 9,156,914 - Blanchetot , et al. October 13, 2
2015-10-13
FCRN Antagonists and Methods of Use
App 20150218239 - Ulrichts; Peter ;   et al.
2015-08-06
Il-6 Binding Molecules
App 20150140011 - Blanchetot; Christophe ;   et al.
2015-05-21
Amino acid sequences directed against cellular receptors for viruses and bacteria
Grant 9,005,963 - Blanchetot , et al. April 14, 2
2015-04-14
Amino acid sequences directed against chemokines and polypeptides comprising the same for the treatment of chemokine-related diseases and disorders
Grant 8,906,680 - Blanchetot , et al. December 9, 2
2014-12-09
Chimeric Human-llama Antigens And Methods Of Use
App 20140286976 - De Haard; Johannes Joseph Wilhelmus ;   et al.
2014-09-25
Amino Acid Sequences Directed Against Gpcrs And Polypeptides Comprising The Same For The Treatment Of Gpcr-related Diseases And Disorders
App 20130130379 - Adams; Hendrik ;   et al.
2013-05-23
Biparatopic Protein Constructs Directed Against Il-23
App 20120264917 - Saunders; Michael John Scott ;   et al.
2012-10-18
Amino Acid Sequences Targeting Human Cd4, Cxcr4, Ccr5, Tlr4, Alphav Integrin, Beta3-integrin, Beta1-integrin, Human Alpha2-integrin, Cd81, Sr-bi, Claudin-1, Claudin-6 And Claudin-9, Respectively, And Neutralizing Viral Entry
App 20110318347 - Blanchetot; Christophe ;   et al.
2011-12-29
Amino Acid Sequences Directed Against Integrins And Uses Thereof
App 20110294982 - Vanlandschoot; Peter ;   et al.
2011-12-01
Amino Acid Sequences Directed Against Cxcr4 And Other Gpcrs And Compounds Comprising The Same
App 20110206660 - Blanchetot; Christophe ;   et al.
2011-08-25
Amino Acid Sequences Directed Against Heterodimeric Cytokines And/or Their Receptors And Polypeptides Comprising The Same
App 20110053865 - Saunders; Michael John Scott ;   et al.
2011-03-03
Amino Acid Sequences Directed Against A Metalloproteinase From The Adam Family And Polypeptides Comprising The Same For The Treatment Of Adam-related Diseases And Disorders
App 20100150939 - Blanchetot; Christophe ;   et al.
2010-06-17
Amino Acid Sequences Directed Against Chemokines And Polypeptides Comprising The Same For The Treatment Of Chemokine-related Diseases And Disorders
App 20100092460 - Blanchetot; Christophe ;   et al.
2010-04-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed